Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Molecular Diagnostic Stocks Outperform Up 15%+ In 2014

|Includes:ILMN, NanoString Technologies (NSTG), RGDX

2014 J.P. Morgan Conference Update #5-Rayno Diagnostics and Tools Portfolio

Performance among Clinical Diagnostics and Tools stocks was strong with many stocks beating the sector indices (NASDAQ:IBB) which were up 10-15%. Stock performance in 2014 will be more dependent on earnings and guidance although there is considerable sentiment carry-over from biotechnology and healthcare macro trends. Biopharmaceutical stocks are driven more by pipeline, clinical data and deal activity.

Review the chart below and the last two columns give 2014 YTD performance. Columns three and four give original dates and prices of recommendations.

Response Genetics (NASDAQ:RGDX) was up 42% but this is a volatile small cap stock, as is VRML up 19.5%.

Illumina (NASDAQ:ILMN) was up 23.3% . Sequencing is a major tool for molecular medicine.

Exact Sciences (NASDAQ:EXAS) was up 21.8 % anticipating Q2 2014 approval of their DNA colon cancer test.

NanoString (NASDAQ:NSTG) was up 14.8% and was a new pick at $12 in November.

Rayno DX and Tools Portfolio 2013- 2014 Stock Performance

 

 

2010-2013   Original Price Price % Price % RET Price2013 %RET Price % RET
DX and Tools Recomm   Dec'10 Ret 1/2/13 2013 12-Nov YTD 1/20/14 YTD  
                         
Abaxis ABAX 2/2/09 15 26.85 79 37.8 36.7 35.45 -4.45 45 11.4  
CardioV.Sys. CSII 11/5/10 7.15 11.66 63 13 29.7 29.5 135 29.7 -13  
Cepheid CPHD 10/23/12 31.4     35.5 13 41.97 24 48.33 4  
Exact Sci EXAS 12/10/10 5.6 5.98 6.8 11 36 11.52 8.78 14.31 21.8  
GenomicH GHDX 2/26/13 28.5     27.24 6.3 34.45 26.5 32.5 11  
GenProbe GPRO 2/2/09 45 58.35 30 acq       n/a    
Hologic HOLX* 4/9/13 21.6     20   20.51 2.5 22.58 1  
Illumina ILMN 2/2/09 29 63.34 118 55.4 81.8 96.52 73.6 136.3 23.3  
Alere ALR 2/2/09 25 36.6 46 19 -17.7 33.57 81.5 38.6 6.6  
NeoGen NEOG 7/2/10 26 41.03 58 45.6 48.8 46.78 3.22 43.2 5.5  
NanoString NSTG 11/21/13 12         11.3   19.8 14.8  
Qiagen QGEN 3/15/10 21.5 19.55 -9 18.8 36 22.95 26.5 24.2 1.68  
Quidel QDEL 6/16/10 12.4 14.45 16 19.9 31.3 24.55 31.5 31.44 1.78  
ResponseG RGDX 2/3/12 1.5     1.4 -12.9 1.25 -10 1.65 42.1  
Sequenom SQNM 11/18/09 3.75 8.03 114 4.93 10.8 2.29 -51.4 2.6 11.1  
ThermoFish TMO** 7/25/12 53.5     65 44.5 97.69 53 115.9 4  
Vermillion VRML 5/15/13 2.53     1.37 73 2.54 92 2.82 19.5  
                         
*HOLX acq GPRO                      
**TMO acq LIFE                      
                         
Click to enlarge

Disclosure: I am long CSII, CPHD, NSTG, RGDX, HOLX, .

Additional disclosure: I am long Fidelity Select Biotechnology Fund (MUTF:FBIOX)

Stocks: NSTG, ILMN, RGDX